Our current research projects

Our current and recent research activity is rich and varied.

Research at Sue Ryder

As an established and respected provider of excellence in palliative and neurological care, Sue Ryder is well placed to adopt a key position in the national research community, supporting and influencing the development of palliative and neurological care research, and its translation into improved clinical practice. Sue Ryder has engaged in important clinical research for many years. Studies have ranged from small-scale academic projects by Masters students to national commercial clinical drug trials.

Within Sue Ryder, we are working together to nurture an inclusive research culture. Our goal is to foster curiosity, and turn this curiosity into innovative and progressive practice by engaging our staff, volunteers, service users, their families and carers in research and making participation the norm.

Research at Sue Ryder is supported and governed by a dedicated Research Governance Group (RGG). The RGG meets quarterly to discuss, review and approve existing and potential research projects, and to produce, develop and maintain robust research governance documents, polices, strategies and processes.

Our Research Lead acts as a first point of contact for research within and without the organisation and coordinates and develops research within Sue Ryder.

Why do we need research?

Research plays an essential role in the discovery and implementation of the best possible, evidence-based care for our own patients and service users, and for those in the wider palliative and neurological care environments.

Through research we review and challenge current practice, and continue to ask the vital question 'Are we doing the best we can?' The discoveries that are made through research lead to advances and improvements in treatments, therapies and approaches to care.

 

Our current research projects

OPEL (Optimum Hospice at Home Services for End of Life Care) Phase 2 (Phase 1 completed)

Sponsor – University of Kent

A three-year mixed methods study exploring hospice at home care models including their impact on patient and carer outcomes, the costs and resource implications of patient care in different hospice at home models; experiences of patients, family carers, providers and commissioners; enablers and barriers to embedding hospice at home models.

Download the summary outcomes of Phase 1

MEPFAC – Methylphenamide versus placebo for fatigue in advanced cancer (Phase III CTIMP; NIHR HTA funded)

Sponsor – University College London (UCL)

This study will involve patients with advanced cancer with cancer-related fatigue who are receiving palliative care. The aim of the study is to estimate clinical effectiveness of methylphenidate versus placebo for cancer-related fatigue in patients receiving specialist palliative care.

Does acupressure help reduce nausea and vomiting in palliative care patients?

Sponsor – Gloucestershire Hospital NHS Foundation Trust

A randomised trial to determine whether acupressure at the P6 site can help in the treatment of nausea and vomiting suffered by palliative care patients.

SIP Study – Exploratory study of behaviours of patients who take their strong opioids as unmeasured sips

Sponsor – Gloucestershire Hospital NHS Foundation Trust

A prospective, observational study wherein a patient or relatives/carers are trained to use a simple scale to measure the mass of a bottle of the opioid before and after 2 doses of breakthrough strong opioid has been taken in unmeasured sips

StOIC Study: An observational Study of diagnostic criteria, clinical features and management of Opioid Induced Constipation (OIC) in patients with cancer pain

Sponsor: The Royal Surrey County Hospital NHS Foundation Trust

The aim of the study is to investigate OIC in a real world/heterogeneous group of patients with cancer. Objectives are to determine: Prevalence of OIC; Clinical features/impact of OIC; Efficacy of a treatment algorithm to manage OIC; Efficacy of conventional laxatives to manage OIC Efficacy of PAMORAs/other interventions to manage OIC.

The project consists of 2 parts: Study 1 is an observational study investigating the diagnostic criteria and clinical features of OIC. Study 2 is an observational study investigating the management of OIC (using a treatment algorithm rather than a specific intervention).

CARiAD – Carer-administration of as needed subcutaneous medication for breakthrough symptoms in home based dying patients

Sue Ryder Research Nurse will be recruiting to and delivering the study by virtue of an Honorary Contract with Gloucestershire NHS Trust.

Contact our Research Lead

Want to know more about our research or collaborate with us? Call 07816 644 076 or email now.